MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response.

Saved in:
Bibliographic Details
Title: MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response.
Authors: Wan J; Mass General Cancer Center , Harvard Medical School, Boston, Massachusetts., Saatcioglu HD; Servier BioInnovation , Boston, Massachusetts., Ellis H; Mass General Cancer Center , Harvard Medical School, Boston, Massachusetts., Aguado-Fraile E; Agios Pharmaceuticals, Inc. , Cambridge, Massachusetts., Xu Q; Mass General Cancer Center , Harvard Medical School, Boston, Massachusetts., Kondo H; Mass General Cancer Center , Harvard Medical School, Boston, Massachusetts., Manguso RT; Mass General Cancer Center , Harvard Medical School, Boston, Massachusetts., Gritti I; Mass General Cancer Center , Harvard Medical School, Boston, Massachusetts., Norden BL; Mass General Cancer Center , Harvard Medical School, Boston, Massachusetts., Noble C; Mass General Cancer Center , Harvard Medical School, Boston, Massachusetts., Corcoran RB; Mass General Cancer Center , Harvard Medical School, Boston, Massachusetts., Lubner SJ; University of Wisconsin Hospital and Clinics , Madison, Wisconsin., Javle M; MD Anderson Cancer Center , Houston, Texas., Abou-Alfa GK; Memorial Sloan Kettering Cancer Center , New York, New York.; Weill Medical College at Cornel University, New York, New York.; Trinity College Dublin, Dublin, Ireland., Cleary JM; Dana Farber Cancer Institute , Boston, Massachusetts., Kelley RK; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California., Borad MJ; Mayo Clinic , Scottsdale, Arizona., Macarulla T; Hospital Universitario Vall d'Hebron, Vall d'hebron Institute of Oncology (VHIO), Barcelona, Spain., Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., Daigle S; Servier BioInnovation , Boston, Massachusetts., Gliser C; Servier BioInnovation , Boston, Massachusetts., Pandya S; Servier BioInnovation , Boston, Massachusetts., Choe S; Servier BioInnovation , Boston, Massachusetts., Tron AE; Servier BioInnovation , Boston, Massachusetts., Bardeesy N; Mass General Cancer Center , Harvard Medical School, Boston, Massachusetts.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Mar 02; Vol. 32 (5), pp. 925-937.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-25-3284